Market Executive Summary
The global Embolization Particle market size was US$ 2012.7 million in 2023 and is forecast to a readjusted size of US$ 5248.9 million by 2030 with a CAGR of 14.5% during the forecast period 2024-2030.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
In terms of sales (consumption) side, this report focuses on the sales of Embolization Particle by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global Embolization Particle market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Embolization Particle market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
Global Embolization Particle Companies Covered
Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon
Global Embolization Particle Market, Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Global Embolization Particle Market, Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Embolization Particle in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolization Particle sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Report Overview
1.1 Embolization Particle Definition
1.2 Market by Type
1.2.1 Global Embolization Particle Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Market Segment by Application
1.3.1 Global Embolization Particle Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Embolization Particle Sales
2.1 Global Embolization Particle Revenue Estimates and Forecasts 2019-2030
2.2 Global Embolization Particle Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Embolization Particle Revenue by Region
2.3.1 Global Embolization Particle Revenue by Region (2019-2024)
2.3.2 Global Embolization Particle Revenue by Region (2025-2030)
2.4 Global Embolization Particle Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Embolization Particle Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Embolization Particle Sales Quantity by Region
2.6.1 Global Embolization Particle Sales Quantity by Region (2019-2024)
2.6.2 Global Embolization Particle Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Embolization Particle Sales Quantity by Manufacturers
3.1.1 Global Embolization Particle Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Embolization Particle Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Embolization Particle Sales in 2023
3.2 Global Embolization Particle Revenue by Manufacturers
3.2.1 Global Embolization Particle Revenue by Manufacturers (2019-2024)
3.2.2 Global Embolization Particle Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Embolization Particle Revenue in 2023
3.3 Global Embolization Particle Sales Price by Manufacturers
3.4 Global Key Players of Embolization Particle, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Embolization Particle, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Embolization Particle, Product Offered and Application
3.8 Global Key Manufacturers of Embolization Particle, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Embolization Particle Sales Quantity by Type
4.1.1 Global Embolization Particle Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Embolization Particle Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Embolization Particle Sales Quantity Market Share by Type (2019-2030)
4.2 Global Embolization Particle Revenue by Type
4.2.1 Global Embolization Particle Historical Revenue by Type (2019-2024)
4.2.2 Global Embolization Particle Forecasted Revenue by Type (2025-2030)
4.2.3 Global Embolization Particle Revenue Market Share by Type (2019-2030)
4.3 Global Embolization Particle Price by Type
4.3.1 Global Embolization Particle Price by Type (2019-2024)
4.3.2 Global Embolization Particle Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Embolization Particle Sales Quantity by Application
5.1.1 Global Embolization Particle Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Embolization Particle Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Embolization Particle Sales Quantity Market Share by Application (2019-2030)
5.2 Global Embolization Particle Revenue by Application
5.2.1 Global Embolization Particle Historical Revenue by Application (2019-2024)
5.2.2 Global Embolization Particle Forecasted Revenue by Application (2025-2030)
5.2.3 Global Embolization Particle Revenue Market Share by Application (2019-2030)
5.3 Global Embolization Particle Price by Application
5.3.1 Global Embolization Particle Price by Application (2019-2024)
5.3.2 Global Embolization Particle Price Forecast by Application (2025-2030)
6 North America
6.1 North America Embolization Particle Sales by Company
6.1.1 North America Embolization Particle Revenue by Company (2019-2024)
6.1.2 North America Embolization Particle Sales Quantity by Company (2019-2024)
6.2 North America Embolization Particle Market Size by Type
6.2.1 North America Embolization Particle Sales Quantity by Type (2019-2030)
6.2.2 North America Embolization Particle Revenue by Type (2019-2030)
6.3 North America Embolization Particle Market Size by Application
6.3.1 North America Embolization Particle Sales Quantity by Application (2019-2030)
6.3.2 North America Embolization Particle Revenue by Application (2019-2030)
6.4 North America Embolization Particle Market Size by Country
6.4.1 North America Embolization Particle Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Embolization Particle Revenue by Country (2019-2030)
6.4.3 North America Embolization Particle Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Embolization Particle Sales by Company
7.1.1 Europe Embolization Particle Sales Quantity by Company (2019-2024)
7.1.2 Europe Embolization Particle Revenue by Company (2019-2024)
7.2 Europe Embolization Particle Market Size by Type
7.2.1 Europe Embolization Particle Sales Quantity by Type (2019-2030)
7.2.2 Europe Embolization Particle Revenue by Type (2019-2030)
7.3 Europe Embolization Particle Market Size by Application
7.3.1 Europe Embolization Particle Sales Quantity by Application (2019-2030)
7.3.2 Europe Embolization Particle Revenue by Application (2019-2030)
7.4 Europe Embolization Particle Market Size by Country
7.4.1 Europe Embolization Particle Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Embolization Particle Revenue by Country (2019-2030)
7.4.3 Europe Embolization Particle Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Embolization Particle Sales by Company
8.1.1 China Embolization Particle Sales Quantity by Company (2019-2024)
8.1.2 China Embolization Particle Revenue by Company (2019-2024)
8.2 China Embolization Particle Market Size by Type
8.2.1 China Embolization Particle Sales Quantity by Type (2019-2030)
8.2.2 China Embolization Particle Revenue by Type (2019-2030)
8.3 China Embolization Particle Market Size by Application
8.3.1 China Embolization Particle Sales Quantity by Application (2019-2030)
8.3.2 China Embolization Particle Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Embolization Particle Sales by Company
9.1.1 APAC Embolization Particle Sales Quantity by Company (2019-2024)
9.1.2 APAC Embolization Particle Revenue by Company (2019-2024)
9.2 APAC Embolization Particle Market Size by Type
9.2.1 APAC Embolization Particle Sales Quantity by Type (2019-2030)
9.2.2 APAC Embolization Particle Revenue by Type (2019-2030)
9.3 APAC Embolization Particle Market Size by Application
9.3.1 APAC Embolization Particle Sales Quantity by Application (2019-2030)
9.3.2 APAC Embolization Particle Revenue by Application (2019-2030)
9.4 APAC Embolization Particle Market Size by Region
9.4.1 APAC Embolization Particle Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Embolization Particle Revenue by Region (2019-2030)
9.4.3 APAC Embolization Particle Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Embolization Particle Sales by Company
10.1.1 Middle East, Africa and Latin America Embolization Particle Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Embolization Particle Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Embolization Particle Market Size by Type
10.2.1 Middle East, Africa and Latin America Embolization Particle Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Embolization Particle Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Embolization Particle Market Size by Application
10.3.1 Middle East, Africa and Latin America Embolization Particle Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Embolization Particle Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Embolization Particle Market Size by Country
10.4.1 Middle East, Africa and Latin America Embolization Particle Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Embolization Particle Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Embolization Particle Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sirtex Medical
11.1.1 Sirtex Medical Company Information
11.1.2 Sirtex Medical Overview
11.1.3 Sirtex Medical Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Sirtex Medical Embolization Particle Products and Services
11.1.5 Sirtex Medical Embolization Particle SWOT Analysis
11.1.6 Sirtex Medical Recent Developments
11.2 Merit Medical
11.2.1 Merit Medical Company Information
11.2.2 Merit Medical Overview
11.2.3 Merit Medical Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Merit Medical Embolization Particle Products and Services
11.2.5 Merit Medical Embolization Particle SWOT Analysis
11.2.6 Merit Medical Recent Developments
11.3 Cook Medical
11.3.1 Cook Medical Company Information
11.3.2 Cook Medical Overview
11.3.3 Cook Medical Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Cook Medical Embolization Particle Products and Services
11.3.5 Cook Medical Embolization Particle SWOT Analysis
11.3.6 Cook Medical Recent Developments
11.4 BTG Medical
11.4.1 BTG Medical Company Information
11.4.2 BTG Medical Overview
11.4.3 BTG Medical Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 BTG Medical Embolization Particle Products and Services
11.4.5 BTG Medical Embolization Particle SWOT Analysis
11.4.6 BTG Medical Recent Developments
11.5 Boston Scientific Corporation
11.5.1 Boston Scientific Corporation Company Information
11.5.2 Boston Scientific Corporation Overview
11.5.3 Boston Scientific Corporation Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Boston Scientific Corporation Embolization Particle Products and Services
11.5.5 Boston Scientific Corporation Embolization Particle SWOT Analysis
11.5.6 Boston Scientific Corporation Recent Developments
11.6 Terumo Corporation
11.6.1 Terumo Corporation Company Information
11.6.2 Terumo Corporation Overview
11.6.3 Terumo Corporation Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Terumo Corporation Embolization Particle Products and Services
11.6.5 Terumo Corporation Embolization Particle SWOT Analysis
11.6.6 Terumo Corporation Recent Developments
11.7 HENGRUI Medical
11.7.1 HENGRUI Medical Company Information
11.7.2 HENGRUI Medical Overview
11.7.3 HENGRUI Medical Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 HENGRUI Medical Embolization Particle Products and Services
11.7.5 HENGRUI Medical Embolization Particle SWOT Analysis
11.7.6 HENGRUI Medical Recent Developments
11.8 INterface BIOmaterials B.V.
11.8.1 INterface BIOmaterials B.V. Company Information
11.8.2 INterface BIOmaterials B.V. Overview
11.8.3 INterface BIOmaterials B.V. Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 INterface BIOmaterials B.V. Embolization Particle Products and Services
11.8.5 INterface BIOmaterials B.V. Embolization Particle SWOT Analysis
11.8.6 INterface BIOmaterials B.V. Recent Developments
11.9 Alicon
11.9.1 Alicon Company Information
11.9.2 Alicon Overview
11.9.3 Alicon Embolization Particle Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 Alicon Embolization Particle Products and Services
11.9.5 Alicon Embolization Particle SWOT Analysis
11.9.6 Alicon Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Embolization Particle Value Chain Analysis
12.2 Embolization Particle Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Embolization Particle Production Mode & Process
12.4 Embolization Particle Sales and Marketing
12.4.1 Embolization Particle Sales Channels
12.4.2 Embolization Particle Distributors
12.5 Embolization Particle Customers
13 Market Dynamics
13.1 Embolization Particle Industry Trends
13.2 Embolization Particle Market Drivers
13.3 Embolization Particle Market Challenges
13.4 Embolization Particle Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figures
List of Tables
Table 1. Global Embolization Particle Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Microspheres
Table 3. Major Manufacturers of Particles (e.g. PVA Particles, Gelfoam Particles)
Table 4. Major Manufacturers of Drug-eluting Beads (DEBs)
Table 5. Major Manufacturers of Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Table 6. Global Embolization Particle Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Embolization Particle Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Embolization Particle Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Embolization Particle Revenue Market Share by Region (2019-2024)
Table 10. Global Embolization Particle Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Embolization Particle Revenue Market Share by Region (2025-2030)
Table 12. Global Embolization Particle Sales Quantity by Region: 2019 VS 2023 VS 2030 (K Units)
Table 13. Global Embolization Particle Sales by Region (2019-2024) & (K Units)
Table 14. Global Embolization Particle Sales Market Share by Region (2019-2024)
Table 15. Global Embolization Particle Sales by Region (2025-2030) & (K Units)
Table 16. Global Embolization Particle Sales Market Share by Region (2025-2030)
Table 17. Global Embolization Particle Sales Quantity by Manufacturers (2019-2024) & (K Units)
Table 18. Global Embolization Particle Sales Quantity Share by Manufacturers (2019-2024)
Table 19. Global Embolization Particle Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Embolization Particle Revenue Share by Manufacturers (2019-2024)
Table 21. Global Embolization Particle Price by Manufacturers 2019-2024 (USD/Unit)
Table 22. Global Key Players of Embolization Particle, Industry Ranking, 2022 VS 2023
Table 23. Global Embolization Particle Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Embolization Particle by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Embolization Particle as of 2023)
Table 25. Global Key Manufacturers of Embolization Particle, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Embolization Particle, Product Offered and Application
Table 27. Global Key Manufacturers of Embolization Particle, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Embolization Particle Sales Quantity by Type (2019-2024) & (K Units)
Table 30. Global Embolization Particle Sales Quantity by Type (2025-2030) & (K Units)
Table 31. Global Embolization Particle Sales Quantity Share by Type (2019-2024)
Table 32. Global Embolization Particle Sales Quantity Share by Type (2025-2030)
Table 33. Global Embolization Particle Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Embolization Particle Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Embolization Particle Revenue Share by Type (2019-2024)
Table 36. Global Embolization Particle Revenue Share by Type (2025-2030)
Table 37. Embolization Particle Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Embolization Particle Price Forecast by Type (2025-2030) & (USD/Unit)
Table 39. Global Embolization Particle Sales Quantity by Application (2019-2024) & (K Units)
Table 40. Global Embolization Particle Sales Quantity by Application (2025-2030) & (K Units)
Table 41. Global Embolization Particle Sales Quantity Share by Application (2019-2024)
Table 42. Global Embolization Particle Sales Quantity Share by Application (2025-2030)
Table 43. Global Embolization Particle Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Embolization Particle Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Embolization Particle Revenue Share by Application (2019-2024)
Table 46. Global Embolization Particle Revenue Share by Application (2025-2030)
Table 47. Embolization Particle Price by Application (2019-2024) & (USD/Unit)
Table 48. Global Embolization Particle Price Forecast by Application (2025-2030) & (USD/Unit)
Table 49. North America Embolization Particle Revenue by Company (2019-2024) & (US$ Million)
Table 50. North America Embolization Particle Sales Quantity by Company (2019-2024) & (K Units)
Table 51. North America Embolization Particle Sales Quantity by Type (2019-2024) & (K Units)
Table 52. North America Embolization Particle Sales Quantity by Type (2025-2030) & (K Units)
Table 53. North America Embolization Particle Revenue by Type (2019-2024) & (US$ Million)
Table 54. North America Embolization Particle Revenue by Type (2025-2030) & (US$ Million)
Table 55. North America Embolization Particle Sales Quantity by Application (2019-2024) & (K Units)
Table 56. North America Embolization Particle Sales Quantity by Application (2025-2030) & (K Units)
Table 57. North America Embolization Particle Revenue by Application (2019-2024) & (US$ Million)
Table 58. North America Embolization Particle Revenue by Application (2025-2030) & (US$ Million)
Table 59. North America Embolization Particle Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. North America Embolization Particle Revenue by Country (2019-2024) & (US$ Million)
Table 61. North America Embolization Particle Revenue by Country (2025-2030) & (US$ Million)
Table 62. North America Embolization Particle Sales Quantity by Country (2019-2024) & (K Units)
Table 63. North America Embolization Particle Sales Quantity by Country (2025-2030) & (K Units)
Table 64. Europe Embolization Particle Sales Quantity by Company (2019-2024) & (K Units)
Table 65. Europe Embolization Particle Revenue by Company (2019-2024) & (US$ Million)
Table 66. Europe Embolization Particle Sales Quantity by Type (2019-2024) & (K Units)
Table 67. Europe Embolization Particle Sales Quantity by Type (2025-2030) & (K Units)
Table 68. Europe Embolization Particle Revenue by Type (2019-2024) & (US$ Million)
Table 69. Europe Embolization Particle Revenue by Type (2025-2030) & (US$ Million)
Table 70. Europe Embolization Particle Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Embolization Particle Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Embolization Particle Revenue by Application (2019-2024) & (US$ Million)
Table 73. Europe Embolization Particle Revenue by Application (2025-2030) & (US$ Million)
Table 74. Europe Embolization Particle Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 75. Europe Embolization Particle Revenue by Country (2019-2024) & (US$ Million)
Table 76. Europe Embolization Particle Revenue by Country (2025-2030) & (US$ Million)
Table 77. Europe Embolization Particle Sales Quantity by Country (2019-2024) & (K Units)
Table 78. Europe Embolization Particle Sales Quantity by Country (2025-2030) & (K Units)
Table 79. China Embolization Particle Sales Quantity by Company (2019-2024) & (K Units)
Table 80. China Embolization Particle Revenue by Company (2019-2024) & (US$ Million)
Table 81. China Embolization Particle Sales Quantity by Type (2019-2024) & (K Units)
Table 82. China Embolization Particle Sales Quantity by Type (2025-2030) & (K Units)
Table 83. China Embolization Particle Revenue by Type (2019-2024) & (US$ Million)
Table 84. China Embolization Particle Revenue by Type (2025-2030) & (US$ Million)
Table 85. China Embolization Particle Sales Quantity by Application (2019-2024) & (K Units)
Table 86. China Embolization Particle Sales Quantity by Application (2025-2030) & (K Units)
Table 87. China Embolization Particle Revenue by Application (2019-2024) & (US$ Million)
Table 88. China Embolization Particle Revenue by Application (2025-2030) & (US$ Million)
Table 89. APAC Embolization Particle Sales Quantity by Company (2019-2024) & (K Units)
Table 90. APAC Embolization Particle Revenue by Company (2019-2024) & (US$ Million)
Table 91. APAC Embolization Particle Sales Quantity by Type (2019-2024) & (K Units)
Table 92. APAC Embolization Particle Sales Quantity by Type (2025-2030) & (K Units)
Table 93. APAC Embolization Particle Revenue by Type (2019-2024) & (US$ Million)
Table 94. APAC Embolization Particle Revenue by Type (2025-2030) & (US$ Million)
Table 95. APAC Embolization Particle Sales Quantity by Application (2019-2024) & (K Units)
Table 96. APAC Embolization Particle Sales Quantity by Application (2025-2030) & (K Units)
Table 97. APAC Embolization Particle Revenue by Application (2019-2024) & (US$ Million)
Table 98. APAC Embolization Particle Revenue by Application (2025-2030) & (US$ Million)
Table 99. APAC Embolization Particle Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 100. APAC Embolization Particle Revenue by Region (2019-2024) & (US$ Million)
Table 101. APAC Embolization Particle Revenue by Region (2025-2030) & (US$ Million)
Table 102. APAC Embolization Particle Sales Quantity by Region (2019-2024) & (K Units)
Table 103. APAC Embolization Particle Sales Quantity by Region (2025-2030) & (K Units)
Table 104. Middle East, Africa and Latin America Embolization Particle Sales Quantity by Company (2019-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Embolization Particle Revenue by Company (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Embolization Particle Sales Quantity by Type (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Embolization Particle Sales Quantity by Type (2025-2030) & (K Units)
Table 108. Middle East, Africa and Latin America Embolization Particle Revenue by Type (2019-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Embolization Particle Revenue by Type (2025-2030) & (US$ Million)
Table 110. Middle East, Africa and Latin America Embolization Particle Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Embolization Particle Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Middle East, Africa and Latin America Embolization Particle Revenue by Application (2019-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Embolization Particle Revenue by Application (2025-2030) & (US$ Million)
Table 114. Middle East, Africa and Latin America Embolization Particle Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 115. Middle East, Africa and Latin America Embolization Particle Revenue by Country (2019-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Embolization Particle Revenue by Country (2025-2030) & (US$ Million)
Table 117. Middle East, Africa and Latin America Embolization Particle Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Middle East, Africa and Latin America Embolization Particle Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Sirtex Medical Company Information
Table 120. Sirtex Medical Description and Overview
Table 121. Sirtex Medical Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 122. Sirtex Medical Embolization Particle Product and Services
Table 123. Sirtex Medical Embolization Particle SWOT Analysis
Table 124. Sirtex Medical Recent Developments
Table 125. Merit Medical Company Information
Table 126. Merit Medical Description and Overview
Table 127. Merit Medical Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 128. Merit Medical Embolization Particle Product and Services
Table 129. Merit Medical Embolization Particle SWOT Analysis
Table 130. Merit Medical Recent Developments
Table 131. Cook Medical Company Information
Table 132. Cook Medical Description and Overview
Table 133. Cook Medical Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 134. Cook Medical Embolization Particle Product and Services
Table 135. Cook Medical Embolization Particle SWOT Analysis
Table 136. Cook Medical Recent Developments
Table 137. BTG Medical Company Information
Table 138. BTG Medical Description and Overview
Table 139. BTG Medical Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 140. BTG Medical Embolization Particle Product and Services
Table 141. BTG Medical Embolization Particle SWOT Analysis
Table 142. BTG Medical Recent Developments
Table 143. Boston Scientific Corporation Company Information
Table 144. Boston Scientific Corporation Description and Overview
Table 145. Boston Scientific Corporation Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 146. Boston Scientific Corporation Embolization Particle Product and Services
Table 147. Boston Scientific Corporation Embolization Particle SWOT Analysis
Table 148. Boston Scientific Corporation Recent Developments
Table 149. Terumo Corporation Company Information
Table 150. Terumo Corporation Description and Overview
Table 151. Terumo Corporation Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 152. Terumo Corporation Embolization Particle Product and Services
Table 153. Terumo Corporation Embolization Particle SWOT Analysis
Table 154. Terumo Corporation Recent Developments
Table 155. HENGRUI Medical Company Information
Table 156. HENGRUI Medical Description and Overview
Table 157. HENGRUI Medical Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 158. HENGRUI Medical Embolization Particle Product and Services
Table 159. HENGRUI Medical Embolization Particle SWOT Analysis
Table 160. HENGRUI Medical Recent Developments
Table 161. INterface BIOmaterials B.V. Company Information
Table 162. INterface BIOmaterials B.V. Description and Overview
Table 163. INterface BIOmaterials B.V. Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 164. INterface BIOmaterials B.V. Embolization Particle Product and Services
Table 165. INterface BIOmaterials B.V. Embolization Particle SWOT Analysis
Table 166. INterface BIOmaterials B.V. Recent Developments
Table 167. Alicon Company Information
Table 168. Alicon Description and Overview
Table 169. Alicon Embolization Particle Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 170. Alicon Embolization Particle Product and Services
Table 171. Alicon Embolization Particle SWOT Analysis
Table 172. Alicon Recent Developments
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Embolization Particle Distributors List
Table 176. Embolization Particle Customers List
Table 177. Embolization Particle Market Trends
Table 178. Embolization Particle Market Drivers
Table 179. Embolization Particle Market Challenges
Table 180. Embolization Particle Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Embolization Particle Product Picture
Figure 2. Global Embolization Particle Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Embolization Particle Market Share by Type in 2023 & 2030
Figure 4. Microspheres Product Picture
Figure 5. Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
Figure 6. Drug-eluting Beads (DEBs) Product Picture
Figure 7. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
Figure 8. Global Embolization Particle Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Embolization Particle Market Share by Application in 2023 & 2030
Figure 10. Uterine Fibroid Embolization
Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Figure 12. Liver Tumor Embolization
Figure 13. Trauma Embolization
Figure 14. Others
Figure 15. Embolization Particle Report Years Considered
Figure 16. Global Embolization Particle Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Embolization Particle Revenue 2019-2030 (US$ Million)
Figure 18. Global Embolization Particle Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global Embolization Particle Sales Quantity 2019-2030 (K Units)
Figure 20. Global Embolization Particle Sales Quantity Market Share by Region (2019-2024)
Figure 21. Global Embolization Particle Sales Quantity Market Share by Region (2025-2030)
Figure 22. North America Embolization Particle Sales Quantity YoY (2019-2030) & (K Units)
Figure 23. North America Embolization Particle Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Europe Embolization Particle Sales Quantity YoY (2019-2030) & (K Units)
Figure 25. Europe Embolization Particle Revenue YoY (2019-2030) & (US$ Million)
Figure 26. China Embolization Particle Sales Quantity YoY (2019-2030) & (K Units)
Figure 27. China Embolization Particle Revenue YoY (2019-2030) & (US$ Million)
Figure 28. APAC Embolization Particle Sales Quantity YoY (2019-2030) & (K Units)
Figure 29. APAC Embolization Particle Revenue YoY (2019-2030) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Embolization Particle Sales Quantity YoY (2019-2030) & (K Units)
Figure 31. Middle East, Africa and Latin America Embolization Particle Revenue YoY (2019-2030) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Embolization Particle Sales Quantity in 2023
Figure 33. The Top 10 and Top 5 Players Market Share by Embolization Particle Revenue in 2023
Figure 34. Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 35. Global Embolization Particle Sales Quantity Market Share by Type (2019-2030)
Figure 36. Global Embolization Particle Revenue Market Share by Type (2019-2030)
Figure 37. Global Embolization Particle Sales Quantity Market Share by Application (2019-2030)
Figure 38. Global Embolization Particle Revenue Market Share by Application (2019-2030)
Figure 39. North America Embolization Particle Revenue Market Share by Company in 2023
Figure 40. North America Embolization Particle Sales Quantity Market Share by Company in 2023
Figure 41. North America Embolization Particle Sales Quantity Market Share by Type (2019-2030)
Figure 42. North America Embolization Particle Revenue Market Share by Type (2019-2030)
Figure 43. North America Embolization Particle Sales Quantity Market Share by Application (2019-2030)
Figure 44. North America Embolization Particle Revenue Market Share by Application (2019-2030)
Figure 45. North America Embolization Particle Revenue Share by Country (2019-2030)
Figure 46. North America Embolization Particle Sales Quantity Share by Country (2019-2030)
Figure 47. U.S. Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 48. Canada Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 49. Europe Embolization Particle Sales Quantity Market Share by Company in 2023
Figure 50. Europe Embolization Particle Revenue Market Share by Company in 2023
Figure 51. Europe Embolization Particle Sales Quantity Market Share by Type (2019-2030)
Figure 52. Europe Embolization Particle Revenue Market Share by Type (2019-2030)
Figure 53. Europe Embolization Particle Sales Quantity Market Share by Application (2019-2030)
Figure 54. Europe Embolization Particle Revenue Market Share by Application (2019-2030)
Figure 55. Europe Embolization Particle Revenue Share by Country (2019-2030)
Figure 56. Europe Embolization Particle Sales Quantity Share by Country (2019-2030)
Figure 57. Germany Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 58. France Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 59. U.K. Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 60. Italy Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 61. Russia Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 62. China Embolization Particle Sales Quantity Market Share by Company in 2023
Figure 63. China Embolization Particle Revenue Market Share by Company in 2023
Figure 64. China Embolization Particle Sales Quantity Market Share by Type (2019-2030)
Figure 65. China Embolization Particle Revenue Market Share by Type (2019-2030)
Figure 66. China Embolization Particle Sales Quantity Market Share by Application (2019-2030)
Figure 67. China Embolization Particle Revenue Market Share by Application (2019-2030)
Figure 68. APAC Embolization Particle Sales Quantity Market Share by Company in 2023
Figure 69. APAC Embolization Particle Revenue Market Share by Company in 2023
Figure 70. APAC Embolization Particle Sales Quantity Market Share by Type (2019-2030)
Figure 71. APAC Embolization Particle Revenue Market Share by Type (2019-2030)
Figure 72. APAC Embolization Particle Sales Quantity Market Share by Application (2019-2030)
Figure 73. APAC Embolization Particle Revenue Market Share by Application (2019-2030)
Figure 74. APAC Embolization Particle Revenue Share by Region (2019-2030)
Figure 75. APAC Embolization Particle Sales Quantity Share by Region (2019-2030)
Figure 76. Japan Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 77. South Korea Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 78. China Taiwan Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 79. Southeast Asia Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 80. India Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Embolization Particle Sales Quantity Market Share by Company in 2023
Figure 82. Middle East, Africa and Latin America Embolization Particle Revenue Market Share by Company in 2023
Figure 83. Middle East, Africa and Latin America Embolization Particle Sales Quantity Market Share by Type (2019-2030)
Figure 84. Middle East, Africa and Latin America Embolization Particle Revenue Market Share by Type (2019-2030)
Figure 85. Middle East, Africa and Latin America Embolization Particle Sales Quantity Market Share by Application (2019-2030)
Figure 86. Middle East, Africa and Latin America Embolization Particle Revenue Market Share by Application (2019-2030)
Figure 87. Middle East, Africa and Latin America Embolization Particle Sales Quantity Share by Country (2019-2030)
Figure 88. Middle East, Africa and Latin America Embolization Particle Revenue Share by Country (2019-2030)
Figure 89. Brazil Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 90. Mexico Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 91. Turkey Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 92. Israel Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 93. GCC Countries Embolization Particle Revenue (2019-2030) & (US$ Million)
Figure 94. Embolization Particle Value Chain
Figure 95. Embolization Particle Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
